|Articles|March 2, 2016
- Pharmaceutical Technology-03-02-2016
- Volume 40
- Issue 3
FDA GDUFA Testimony Presentation Slides
Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.
Advertisement
Slides from the FDA GDUFA presentation before the Senate Health, Education, Labor and Pensions Committee in January 2016.
Articles in this issue
almost 10 years ago
Gaining Insight from Process Control Dataalmost 10 years ago
Designing a Biomanufacturing Facility Incorporating Single-Use Technologiesalmost 10 years ago
Generic-Drug Production and Oversight Challenge FDA and Manufacturersalmost 10 years ago
Phase-Appropriate GMPalmost 10 years ago
How Important is Data Integrity to Regulatory Bodies?almost 10 years ago
Keynote Series Addresses Crucial Industry Issuesalmost 10 years ago
Polymorph Screening for Identification of Relevant Crystalline Formsalmost 10 years ago
Building Consensus for E&L Testing Standardsalmost 10 years ago
Multimode Microplate Reader Improves Sensitivityalmost 10 years ago
High-Pressure Ion Chromatography SystemNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
3
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
